| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyBiologicalProcess | cardiac muscle adaptation | 3.24e-06 | 43 | 49 | 4 | GO:0014887 | |
| GeneOntologyBiologicalProcess | sarcomere organization | 1.16e-05 | 59 | 49 | 4 | GO:0045214 | |
| GeneOntologyBiologicalProcess | striated muscle adaptation | 2.71e-05 | 73 | 49 | 4 | GO:0014888 | |
| GeneOntologyBiologicalProcess | myofibril assembly | 5.17e-05 | 86 | 49 | 4 | GO:0030239 | |
| GeneOntologyBiologicalProcess | striated muscle cell development | 5.92e-05 | 89 | 49 | 4 | GO:0055002 | |
| GeneOntologyBiologicalProcess | cardiac muscle hypertrophy in response to stress | 1.36e-04 | 42 | 49 | 3 | GO:0014898 | |
| GeneOntologyBiologicalProcess | muscle hypertrophy in response to stress | 1.36e-04 | 42 | 49 | 3 | GO:0003299 | |
| GeneOntologyBiologicalProcess | muscle cell differentiation | 2.42e-04 | 531 | 49 | 7 | GO:0042692 | |
| GeneOntologyBiologicalProcess | actomyosin structure organization | 2.52e-04 | 239 | 49 | 5 | GO:0031032 | |
| GeneOntologyBiologicalProcess | muscle system process | 2.90e-04 | 547 | 49 | 7 | GO:0003012 | |
| GeneOntologyBiologicalProcess | striated muscle cell differentiation | 3.14e-04 | 391 | 49 | 6 | GO:0051146 | |
| GeneOntologyBiologicalProcess | cardiac muscle hypertrophy | 3.59e-04 | 142 | 49 | 4 | GO:0003300 | |
| GeneOntologyBiologicalProcess | muscle cell development | 3.65e-04 | 259 | 49 | 5 | GO:0055001 | |
| GeneOntologyBiologicalProcess | ventricular cardiac muscle tissue morphogenesis | 3.73e-04 | 59 | 49 | 3 | GO:0055010 | |
| GeneOntologyBiologicalProcess | striated muscle hypertrophy | 3.99e-04 | 146 | 49 | 4 | GO:0014897 | |
| GeneOntologyBiologicalProcess | muscle hypertrophy | 4.20e-04 | 148 | 49 | 4 | GO:0014896 | |
| GeneOntologyBiologicalProcess | regulation of sarcomere organization | 4.24e-04 | 13 | 49 | 2 | GO:0060297 | |
| GeneOntologyBiologicalProcess | negative regulation of vascular associated smooth muscle cell differentiation | 4.24e-04 | 13 | 49 | 2 | GO:1905064 | |
| GeneOntologyBiologicalProcess | cellular component assembly involved in morphogenesis | 5.12e-04 | 156 | 49 | 4 | GO:0010927 | |
| GeneOntologyBiologicalProcess | cellular anatomical entity morphogenesis | 5.12e-04 | 156 | 49 | 4 | GO:0032989 | |
| GeneOntologyBiologicalProcess | muscle filament sliding | 5.69e-04 | 15 | 49 | 2 | GO:0030049 | |
| GeneOntologyBiologicalProcess | muscle adaptation | 6.18e-04 | 164 | 49 | 4 | GO:0043500 | |
| GeneOntologyBiologicalProcess | ventricular cardiac muscle tissue development | 7.84e-04 | 76 | 49 | 3 | GO:0003229 | |
| GeneOntologyBiologicalProcess | heart process | 8.12e-04 | 309 | 49 | 5 | GO:0003015 | |
| GeneOntologyBiologicalProcess | cardiac muscle tissue morphogenesis | 8.15e-04 | 77 | 49 | 3 | GO:0055008 | |
| GeneOntologyBiologicalProcess | cardiac muscle cell differentiation | 8.22e-04 | 177 | 49 | 4 | GO:0055007 | |
| GeneOntologyBiologicalProcess | adult heart development | 8.26e-04 | 18 | 49 | 2 | GO:0007512 | |
| GeneOntologyBiologicalProcess | actin-myosin filament sliding | 8.26e-04 | 18 | 49 | 2 | GO:0033275 | |
| GeneOntologyBiologicalProcess | muscle structure development | 8.61e-04 | 858 | 49 | 8 | GO:0061061 | |
| GeneOntologyBiologicalProcess | regulation of skeletal muscle contraction | 1.02e-03 | 20 | 49 | 2 | GO:0014819 | |
| GeneOntologyBiologicalProcess | cardiac muscle tissue development | 1.05e-03 | 327 | 49 | 5 | GO:0048738 | |
| MousePheno | increased uterus leiomyoma incidence | 2.15e-05 | 3 | 38 | 2 | MP:0003570 | |
| MousePheno | increased cystadenoma incidence | 2.15e-05 | 3 | 38 | 2 | MP:0013751 | |
| MousePheno | increased leiomyoma incidence | 2.15e-05 | 3 | 38 | 2 | MP:0003569 | |
| Domain | Myosin_N | 6.37e-04 | 15 | 47 | 2 | PF02736 | |
| Domain | Myosin_N | 6.37e-04 | 15 | 47 | 2 | IPR004009 | |
| Domain | Myosin_tail_1 | 9.24e-04 | 18 | 47 | 2 | PF01576 | |
| Domain | Myosin_tail | 9.24e-04 | 18 | 47 | 2 | IPR002928 | |
| Domain | Myosin-like_IQ_dom | 1.03e-03 | 19 | 47 | 2 | IPR027401 | |
| Domain | - | 1.03e-03 | 19 | 47 | 2 | 4.10.270.10 | |
| Domain | Myosin_head_motor_dom | 4.11e-03 | 38 | 47 | 2 | IPR001609 | |
| Domain | MYOSIN_MOTOR | 4.11e-03 | 38 | 47 | 2 | PS51456 | |
| Domain | Myosin_head | 4.11e-03 | 38 | 47 | 2 | PF00063 | |
| Domain | MYSc | 4.11e-03 | 38 | 47 | 2 | SM00242 | |
| Domain | Acyl_CoA_acyltransferase | 5.73e-03 | 45 | 47 | 2 | IPR016181 | |
| Domain | CUB | 6.76e-03 | 49 | 47 | 2 | PF00431 | |
| Domain | CUB | 7.03e-03 | 50 | 47 | 2 | SM00042 | |
| Domain | - | 7.59e-03 | 52 | 47 | 2 | 2.60.120.290 | |
| Domain | CUB | 7.87e-03 | 53 | 47 | 2 | PS01180 | |
| Domain | Glycoside_hydrolase_SF | 7.87e-03 | 53 | 47 | 2 | IPR017853 | |
| Domain | CUB_dom | 9.06e-03 | 57 | 47 | 2 | IPR000859 | |
| Pubmed | 3.13e-07 | 10 | 49 | 3 | 27052172 | ||
| Pubmed | 7.44e-07 | 13 | 49 | 3 | 34838591 | ||
| Pubmed | Interaction of Gata4 and Gata6 with Tbx5 is critical for normal cardiac development. | 9.46e-07 | 14 | 49 | 3 | 19084512 | |
| Pubmed | 1.18e-06 | 15 | 49 | 3 | 17468400 | ||
| Pubmed | 1.45e-06 | 16 | 49 | 3 | 20007915 | ||
| Pubmed | 1.94e-06 | 2 | 49 | 2 | 21526716 | ||
| Pubmed | 1.94e-06 | 2 | 49 | 2 | 18480046 | ||
| Pubmed | Murine pulmonary myocardium: developmental analysis of cardiac gene expression. | 1.94e-06 | 2 | 49 | 2 | 7919499 | |
| Pubmed | 1.94e-06 | 2 | 49 | 2 | 34384224 | ||
| Pubmed | 1.94e-06 | 2 | 49 | 2 | 2726733 | ||
| Pubmed | Human cardiac myosin heavy chain gene mapped within chromosome region 14q11.2----q13. | 1.94e-06 | 2 | 49 | 2 | 2494889 | |
| Pubmed | Human cardiac myosin heavy chain genes and their linkage in the genome. | 1.94e-06 | 2 | 49 | 2 | 3037493 | |
| Pubmed | 1.94e-06 | 2 | 49 | 2 | 21778428 | ||
| Pubmed | Structural organization of the human cardiac alpha-myosin heavy chain gene (MYH6). | 1.94e-06 | 2 | 49 | 2 | 8307559 | |
| Pubmed | 1.94e-06 | 2 | 49 | 2 | 2969919 | ||
| Pubmed | 1.94e-06 | 2 | 49 | 2 | 24224850 | ||
| Pubmed | 1.94e-06 | 2 | 49 | 2 | 17575272 | ||
| Pubmed | 1.94e-06 | 2 | 49 | 2 | 26192751 | ||
| Pubmed | 1.94e-06 | 2 | 49 | 2 | 16088376 | ||
| Pubmed | 1.94e-06 | 2 | 49 | 2 | 1776652 | ||
| Pubmed | 1.94e-06 | 2 | 49 | 2 | 9884344 | ||
| Pubmed | 1.94e-06 | 2 | 49 | 2 | 12750067 | ||
| Pubmed | 1.94e-06 | 2 | 49 | 2 | 9541509 | ||
| Pubmed | 1.94e-06 | 2 | 49 | 2 | 23580644 | ||
| Pubmed | 1.94e-06 | 2 | 49 | 2 | 38755129 | ||
| Pubmed | 1.94e-06 | 2 | 49 | 2 | 24829265 | ||
| Pubmed | Cardiac myosin heavy chain mRNA expression and myocardial function in the mouse heart. | 1.94e-06 | 2 | 49 | 2 | 2036722 | |
| Pubmed | 1.94e-06 | 2 | 49 | 2 | 25937279 | ||
| Pubmed | DNMT1 mediated promoter methylation of GNAO1 in hepatoma carcinoma cells. | 1.94e-06 | 2 | 49 | 2 | 29709639 | |
| Pubmed | Myocardial contraction is 5-fold more economical in ventricular than in atrial human tissue. | 1.94e-06 | 2 | 49 | 2 | 15621050 | |
| Pubmed | 5.83e-06 | 3 | 49 | 2 | 8620598 | ||
| Pubmed | 5.83e-06 | 3 | 49 | 2 | 18362229 | ||
| Pubmed | Myosin heavy chain gene expression in mouse embryoid bodies. An in vitro developmental study. | 5.83e-06 | 3 | 49 | 2 | 1939265 | |
| Pubmed | 5.83e-06 | 3 | 49 | 2 | 20923879 | ||
| Pubmed | Mouse embryonic stem cells express the cardiac myosin heavy chain genes during development in vitro. | 5.83e-06 | 3 | 49 | 2 | 1694848 | |
| Pubmed | Discordant on/off switching of gene expression in myocytes during cardiac hypertrophy in vivo. | 5.83e-06 | 3 | 49 | 2 | 18755891 | |
| Pubmed | Mutation in myosin heavy chain 6 causes atrial septal defect. | 5.83e-06 | 3 | 49 | 2 | 15735645 | |
| Pubmed | 5.83e-06 | 3 | 49 | 2 | 22966157 | ||
| Pubmed | 5.83e-06 | 3 | 49 | 2 | 11066038 | ||
| Pubmed | 7.51e-06 | 27 | 49 | 3 | 21983003 | ||
| Pubmed | Tbx20 is essential for cardiac chamber differentiation and repression of Tbx2. | 8.40e-06 | 28 | 49 | 3 | 15901664 | |
| Pubmed | 8.95e-06 | 529 | 49 | 7 | 14621295 | ||
| Pubmed | 1.15e-05 | 31 | 49 | 3 | 16554359 | ||
| Pubmed | 1.16e-05 | 4 | 49 | 2 | 9927321 | ||
| Pubmed | 1.16e-05 | 4 | 49 | 2 | 25900833 | ||
| Pubmed | 1.16e-05 | 4 | 49 | 2 | 8482409 | ||
| Pubmed | SZT2 maintains hematopoietic stem cell homeostasis via nutrient-mediated mTORC1 regulation. | 1.16e-05 | 4 | 49 | 2 | 36250465 | |
| Pubmed | TRIM9-dependent ubiquitination of DCC constrains kinase signaling, exocytosis, and axon branching. | 1.16e-05 | 4 | 49 | 2 | 28701345 | |
| Pubmed | A pair of E3 ubiquitin ligases compete to regulate filopodial dynamics and axon guidance. | 1.16e-05 | 4 | 49 | 2 | 31820781 | |
| Pubmed | Sarcomere protein gene mutations in hypertrophic cardiomyopathy of the elderly. | 1.16e-05 | 4 | 49 | 2 | 11815426 | |
| Pubmed | 1.16e-05 | 4 | 49 | 2 | 28806941 | ||
| Pubmed | 1.16e-05 | 4 | 49 | 2 | 9389458 | ||
| Pubmed | 1.64e-05 | 225 | 49 | 5 | 12168954 | ||
| Pubmed | Recruitment of intra- and extracardiac cells into the myocardial lineage during mouse development. | 1.94e-05 | 5 | 49 | 2 | 12629673 | |
| Pubmed | Expression of two myogenic regulatory factors myogenin and MyoD1 during mouse embryogenesis. | 1.94e-05 | 5 | 49 | 2 | 2552320 | |
| Pubmed | 1.94e-05 | 5 | 49 | 2 | 12933792 | ||
| Pubmed | Developmental regulation of myosin gene expression in mouse cardiac muscle. | 1.94e-05 | 5 | 49 | 2 | 2277065 | |
| Pubmed | Mitochondrial fusion directs cardiomyocyte differentiation via calcineurin and Notch signaling. | 1.94e-05 | 5 | 49 | 2 | 24091702 | |
| Pubmed | 1.94e-05 | 5 | 49 | 2 | 17192267 | ||
| Pubmed | TRIP12 and UBR5 suppress spreading of chromatin ubiquitylation at damaged chromosomes. | 1.94e-05 | 5 | 49 | 2 | 22884692 | |
| Pubmed | 2.91e-05 | 6 | 49 | 2 | 28381556 | ||
| Pubmed | The phosphorylation status of PAS-B distinguishes HIF-1alpha from HIF-2alpha in NBS1 repression. | 2.91e-05 | 6 | 49 | 2 | 17024177 | |
| Pubmed | 2.91e-05 | 6 | 49 | 2 | 15383279 | ||
| Pubmed | Mammalian TRIM67 Functions in Brain Development and Behavior. | 2.91e-05 | 6 | 49 | 2 | 29911180 | |
| Pubmed | The E3 Ubiquitin Ligase TRIM9 Is a Filopodia Off Switch Required for Netrin-Dependent Axon Guidance. | 2.91e-05 | 6 | 49 | 2 | 26702829 | |
| Pubmed | 3.54e-05 | 1487 | 49 | 10 | 33957083 | ||
| Pubmed | 4.07e-05 | 7 | 49 | 2 | 21126233 | ||
| Pubmed | 4.07e-05 | 7 | 49 | 2 | 27147649 | ||
| Pubmed | Novel roles of cardiac-derived erythropoietin in cardiac development and function. | 4.07e-05 | 7 | 49 | 2 | 38382296 | |
| Pubmed | 4.07e-05 | 7 | 49 | 2 | 9004034 | ||
| Pubmed | 4.07e-05 | 7 | 49 | 2 | 16819597 | ||
| Pubmed | A threshold of GATA4 and GATA6 expression is required for cardiovascular development. | 5.42e-05 | 8 | 49 | 2 | 16847256 | |
| Pubmed | 5.42e-05 | 8 | 49 | 2 | 3864153 | ||
| Pubmed | A long noncoding RNA protects the heart from pathological hypertrophy. | 5.42e-05 | 8 | 49 | 2 | 25119045 | |
| Pubmed | 5.42e-05 | 8 | 49 | 2 | 28659827 | ||
| Pubmed | Dual function of the UNC-45b chaperone with myosin and GATA4 in cardiac development. | 5.42e-05 | 8 | 49 | 2 | 22553207 | |
| Pubmed | 6.96e-05 | 9 | 49 | 2 | 26487682 | ||
| Pubmed | 6.96e-05 | 9 | 49 | 2 | 11164852 | ||
| Pubmed | 6.96e-05 | 9 | 49 | 2 | 16754800 | ||
| Pubmed | ACMG recommendations for reporting of incidental findings in clinical exome and genome sequencing. | 7.29e-05 | 57 | 49 | 3 | 23788249 | |
| Pubmed | Comparative host-coronavirus protein interaction networks reveal pan-viral disease mechanisms. | 8.52e-05 | 754 | 49 | 7 | 33060197 | |
| Pubmed | 8.69e-05 | 10 | 49 | 2 | 15696166 | ||
| Pubmed | Real-time resolution of point mutations that cause phenovariance in mice. | 8.69e-05 | 10 | 49 | 2 | 25605905 | |
| Pubmed | 8.69e-05 | 10 | 49 | 2 | 10679931 | ||
| Pubmed | 8.93e-05 | 61 | 49 | 3 | 27166947 | ||
| Pubmed | A KRAS-directed transcriptional silencing pathway that mediates the CpG island methylator phenotype. | 1.06e-04 | 11 | 49 | 2 | 24623306 | |
| Pubmed | 1.06e-04 | 11 | 49 | 2 | 31286143 | ||
| Pubmed | 1.06e-04 | 11 | 49 | 2 | 24137001 | ||
| Pubmed | 1.06e-04 | 11 | 49 | 2 | 16374517 | ||
| Pubmed | 1.06e-04 | 11 | 49 | 2 | 20739404 | ||
| Pubmed | 1.06e-04 | 11 | 49 | 2 | 33087478 | ||
| Pubmed | 1.06e-04 | 11 | 49 | 2 | 9486664 | ||
| Pubmed | TACE is required for fetal murine cardiac development and modeling. | 1.27e-04 | 12 | 49 | 2 | 14499647 | |
| Pubmed | 1.27e-04 | 12 | 49 | 2 | 15169892 | ||
| Pubmed | Arrhythmia induced by spatiotemporal overexpression of calreticulin in the heart. | 1.27e-04 | 12 | 49 | 2 | 17482496 | |
| Pubmed | Jumonji, a nuclear protein that is necessary for normal heart development. | 1.27e-04 | 12 | 49 | 2 | 10807864 | |
| Pubmed | 1.27e-04 | 12 | 49 | 2 | 17332425 | ||
| Pubmed | 1.27e-04 | 12 | 49 | 2 | 8424456 | ||
| Pubmed | 1.50e-04 | 13 | 49 | 2 | 21447557 | ||
| Pubmed | 1.50e-04 | 13 | 49 | 2 | 7628699 | ||
| Cytoband | Ensembl 112 genes in cytogenetic band chr15q25 | 6.80e-04 | 160 | 49 | 3 | chr15q25 | |
| Cytoband | 7p14.3 | 7.65e-04 | 38 | 49 | 2 | 7p14.3 | |
| Cytoband | 15q25.2 | 9.80e-04 | 43 | 49 | 2 | 15q25.2 | |
| Cytoband | 14q12 | 1.60e-03 | 55 | 49 | 2 | 14q12 | |
| GeneFamily | Myosin heavy chains | 2.57e-04 | 15 | 29 | 2 | 1098 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 4.28e-03 | 206 | 29 | 3 | 682 | |
| ToppCell | LV-06._Ventricular_Cardiomyocyte_II|LV / Chamber and Cluster_Paper | 2.14e-06 | 191 | 49 | 5 | 25f3eb34f4e70761e81e84c8a5829f216108cbc6 | |
| ToppCell | droplet-Heart-4Chambers-21m-Endothelial|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.97e-05 | 184 | 49 | 4 | f17d713af4a97dff4eeeab24c405677ef2ffcf84 | |
| ToppCell | RV-06._Ventricular_Cardiomyocyte_II|World / Chamber and Cluster_Paper | 5.51e-05 | 189 | 49 | 4 | 5e80c47f63980904c4c1ff02c201b67b456a0974 | |
| ToppCell | Control-T_cells-CD4+_T_cells|Control / group, cell type (main and fine annotations) | 5.63e-05 | 190 | 49 | 4 | 0733be5e54fe15d6d6ea51c154a95258e83f1b92 | |
| ToppCell | LV-06._Ventricular_Cardiomyocyte_II|World / Chamber and Cluster_Paper | 5.63e-05 | 190 | 49 | 4 | de5ef606a002f85c2e0e3a36c1f259d0b85a76ff | |
| ToppCell | RV-06._Ventricular_Cardiomyocyte_II|RV / Chamber and Cluster_Paper | 5.63e-05 | 190 | 49 | 4 | fe8e78922c8ae928ef9a80bffd67868d5a87a091 | |
| ToppCell | COVID-19-lung-CD8+_T_cells|lung / Disease (COVID-19 only), tissue and cell type | 5.98e-05 | 193 | 49 | 4 | 780e23e2705fc5c1b70e37568b79731ced5038bd | |
| ToppCell | 10x5'-Liver-Lymphocytic_T_CD4-Trm_Th1/Th17|Liver / Manually curated celltypes from each tissue | 6.22e-05 | 195 | 49 | 4 | 480cc62ee1e5b1aaf6b62be6e5afd7a81236a1b0 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-Mono-Mono_anti-infl-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 6.73e-05 | 199 | 49 | 4 | 667b8b47a5b388506e3177b46747267fad8024f6 | |
| ToppCell | Parenchymal-NucSeq-Immune_Lymphocytic-T-T_CD4-CD4|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 6.73e-05 | 199 | 49 | 4 | fbdde57dd88656621801e65ee2818251588f3874 | |
| ToppCell | Parenchymal-NucSeq-Immune_Lymphocytic-T-T_CD8-CD8|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 6.73e-05 | 199 | 49 | 4 | 0d6463e368fd611a17327322413fad145f3c7f32 | |
| ToppCell | Parenchymal-NucSeq-Immune_Lymphocytic-T-T_CD8-MAIT|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 6.73e-05 | 199 | 49 | 4 | 036776a03fdd181e51cc655ed99331eec9c63f39 | |
| ToppCell | Parenchymal-NucSeq-Immune_Lymphocytic-T|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 6.86e-05 | 200 | 49 | 4 | dfdfad881c114e1bc9a64b411e1b00fb37cc859b | |
| ToppCell | Parenchymal-NucSeq-Immune_Lymphocytic-T-T_CD8-CD8_GZMK+|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 6.86e-05 | 200 | 49 | 4 | 7a9c3f51d4a8fda5f1b7e0be6fcf9c1c92fffe99 | |
| ToppCell | Parenchymal-NucSeq-Immune_Lymphocytic-T-T_CD3|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 6.86e-05 | 200 | 49 | 4 | 6b34f2b85d4f83c1270ee151f602cba6f42042ba | |
| ToppCell | Bronchial-NucSeq-Immune_Lymphocytic-T-T_CD4-CD4|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 6.86e-05 | 200 | 49 | 4 | 8474e5d031d25bfb8461d39fa2053da01a6304fc | |
| ToppCell | Parenchymal-NucSeq-Immune_Lymphocytic-T-T_CD8|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 6.86e-05 | 200 | 49 | 4 | 66fb892bda1d29e67a65717e85f2ec221f520b2a | |
| ToppCell | Bronchial-NucSeq-Immune_Lymphocytic-T-T_CD8|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 6.86e-05 | 200 | 49 | 4 | 02c4169a23e5aaa0d4bfc78b51ba19ce8157dc3e | |
| ToppCell | Bronchial-NucSeq-Immune_Lymphocytic-T-T_CD8-CD8_TRM|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 6.86e-05 | 200 | 49 | 4 | be9a43acc2f926b9433ab3f018b911b03896a924 | |
| ToppCell | Parenchymal-NucSeq-Immune_Lymphocytic-T-T_CD3-NKT|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 6.86e-05 | 200 | 49 | 4 | b2c5618aa1ac19423996336795dadb39ea57cda7 | |
| ToppCell | Parenchymal-NucSeq-Immune_Lymphocytic-T-T_CD4|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 6.86e-05 | 200 | 49 | 4 | f7a9d8b99de19e9842422bada348d940e0863645 | |
| ToppCell | Bronchial-NucSeq-Immune_Lymphocytic-T-T_CD8-CD8_GZMK+|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 6.86e-05 | 200 | 49 | 4 | 510d84bf7a4621b079e5a7330d25e04508c84a49 | |
| ToppCell | Parenchymal-NucSeq-Immune_Lymphocytic-T-T_CD8-CD8_TRM|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 6.86e-05 | 200 | 49 | 4 | 9ef322486e46e4ff05a8cbe06cf8019e996c94b3 | |
| ToppCell | Bronchial-NucSeq-Immune_Lymphocytic-T-T_CD8-CD8|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 6.86e-05 | 200 | 49 | 4 | 20ffb3436d08042f77800513e6ddb3bbc38ae6fe | |
| ToppCell | Hippocampus-Neuronal-Excitatory-eN1(Slc17a7)-eN1_1-Fibcd1-Excitatory_Neuron.Slc17a7.Fibcd1-Lypd1_(CA1_Principal_cells_(Anterior))|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 1.09e-04 | 84 | 49 | 3 | 52d167614afa9b056f2934142d3250fe5e70e806 | |
| Disease | Hypertrophic obstructive cardiomyopathy | 9.06e-06 | 25 | 48 | 3 | C4551472 | |
| Disease | Caveolinopathy | 1.55e-05 | 4 | 48 | 2 | cv:C5679790 | |
| Disease | CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 1 | 1.55e-05 | 4 | 48 | 2 | 192600 | |
| Disease | Cardiomyopathy, Familial Hypertrophic, 1 (disorder) | 1.55e-05 | 4 | 48 | 2 | C3495498 | |
| Disease | Hypertrophic cardiomyopathy 1 | 1.55e-05 | 4 | 48 | 2 | cv:C3495498 | |
| Disease | Idiopathic hypertrophic subaortic stenosis | 5.41e-05 | 7 | 48 | 2 | C0700053 | |
| Disease | Obstructive asymmetric septal hypertrophy | 5.41e-05 | 7 | 48 | 2 | C0597124 | |
| Disease | Cardiomyopathy, Hypertrophic, Familial | 9.26e-05 | 9 | 48 | 2 | C0949658 | |
| Disease | Hypertrophic Cardiomyopathy | 1.11e-04 | 57 | 48 | 3 | C0007194 | |
| Disease | dilated cardiomyopathy 1S (implicated_via_orthology) | 1.16e-04 | 10 | 48 | 2 | DOID:0110454 (implicated_via_orthology) | |
| Disease | autosomal dominant hyaline body myopathy (implicated_via_orthology) | 1.16e-04 | 10 | 48 | 2 | DOID:0111269 (implicated_via_orthology) | |
| Disease | congenital myopathy 6 (implicated_via_orthology) | 1.16e-04 | 10 | 48 | 2 | DOID:0080719 (implicated_via_orthology) | |
| Disease | Muscular dystrophy, limb-girdle, autosomal dominant | 1.16e-04 | 10 | 48 | 2 | cv:C5675009 | |
| Disease | distal arthrogryposis type 2B3 (implicated_via_orthology) | 1.16e-04 | 10 | 48 | 2 | DOID:0111602 (implicated_via_orthology) | |
| Disease | inclusion body myositis (implicated_via_orthology) | 1.16e-04 | 10 | 48 | 2 | DOID:3429 (implicated_via_orthology) | |
| Disease | distal arthrogryposis type 2A (implicated_via_orthology) | 1.16e-04 | 10 | 48 | 2 | DOID:0111605 (implicated_via_orthology) | |
| Disease | familial hypertrophic cardiomyopathy (implicated_via_orthology) | 1.16e-04 | 10 | 48 | 2 | DOID:0080326 (implicated_via_orthology) | |
| Disease | distal arthrogryposis type 1 (implicated_via_orthology) | 1.16e-04 | 10 | 48 | 2 | DOID:0111596 (implicated_via_orthology) | |
| Disease | distal myopathy (implicated_via_orthology) | 1.69e-04 | 12 | 48 | 2 | DOID:11720 (implicated_via_orthology) | |
| Disease | myotonia congenita (implicated_via_orthology) | 1.69e-04 | 12 | 48 | 2 | DOID:2106 (implicated_via_orthology) | |
| Disease | restrictive cardiomyopathy (implicated_via_orthology) | 2.00e-04 | 13 | 48 | 2 | DOID:397 (implicated_via_orthology) | |
| Disease | distal arthrogryposis (implicated_via_orthology) | 2.68e-04 | 15 | 48 | 2 | DOID:0050646 (implicated_via_orthology) | |
| Disease | nose morphology measurement, mouth morphology measurement | 5.34e-04 | 21 | 48 | 2 | EFO_0007843, EFO_0007955 | |
| Disease | Primary familial hypertrophic cardiomyopathy | 5.86e-04 | 22 | 48 | 2 | cv:C0949658 | |
| Disease | congenital heart disease (is_implicated_in) | 6.99e-04 | 24 | 48 | 2 | DOID:1682 (is_implicated_in) | |
| Disease | Carcinoma, Pancreatic Ductal | 6.99e-04 | 24 | 48 | 2 | C0887833 | |
| Disease | congestive heart failure (biomarker_via_orthology) | 7.12e-04 | 107 | 48 | 3 | DOID:6000 (biomarker_via_orthology) | |
| Disease | Limb-girdle muscular dystrophy | 8.21e-04 | 26 | 48 | 2 | cv:C0686353 | |
| Disease | Primary familial dilated cardiomyopathy | 1.09e-03 | 30 | 48 | 2 | cv:C0340427 | |
| Disease | Cardiomyopathies | 1.25e-03 | 130 | 48 | 3 | C0878544 | |
| Disease | Heart Failure, Diastolic | 1.32e-03 | 33 | 48 | 2 | C1135196 | |
| Disease | Primary dilated cardiomyopathy | 1.41e-03 | 34 | 48 | 2 | cv:C0007193 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| CPNMAMKEADDDEEV | 691 | P26358 | |
| LEEKEMIFRDMAECS | 2376 | Q12802 | |
| DSCISEKLFMEMAEL | 61 | P06280 | |
| MKMTVDFEECLKDSP | 1 | Q15057 | |
| FEPGLMMTCEDIDEC | 2156 | Q75N90 | |
| KLTFMEMDIESQPEC | 786 | P13497 | |
| PMEDFDSLECMEGSD | 41 | Q13323 | |
| MTDTAEAVPKFEEMF | 1 | Q9BTL3 | |
| MSILEEECMFPKATD | 531 | P12883 | |
| MKDFSDVILCMEATE | 1 | Q9BY79 | |
| MKRPCEETTSESDMD | 1 | Q9UBP5 | |
| ECMFETPERVFVVME | 646 | Q15139 | |
| VMTEDPETGTYKDCM | 881 | Q9UI26 | |
| MVFQMPDKDEESRIC | 521 | O95786 | |
| EEMMIFIEASSENPC | 266 | Q8IY47 | |
| MCLVDVPAVAEEFMS | 186 | Q8TDV0 | |
| HECMEIVFGTDMKEV | 151 | A6NCF6 | |
| EEICFMEDAGEVVMP | 681 | Q6ZMV5 | |
| RTSMDEMPIDLCEEE | 291 | Q96T49 | |
| KPEEFISEMDMSCEV | 366 | Q659A1 | |
| IVCMEEFEDMERSLP | 146 | P13284 | |
| QCPEECVMFEDEMSE | 561 | Q0VDD8 | |
| CEDEPMDSTMDDAVA | 111 | O95260 | |
| DMVCDDPEAGEMTSE | 131 | Q9GZR7 | |
| EMSDDENCDSPTKKM | 401 | Q8TC92 | |
| CMMAALPEDTVVFEK | 231 | Q6QHF9 | |
| SMLFTEECDKVRDLM | 3026 | Q5T011 | |
| IAESKSPEMSMQEDC | 506 | O60502 | |
| MEEDFMKPVISIVDE | 341 | Q9HB40 | |
| ADDEITMMVPVESKF | 326 | Q8IZX4 | |
| METIEEMCHEEKVDF | 306 | A1L4K1 | |
| MVCDVVSRMEDTEPF | 106 | P09471 | |
| KLMTPEMFSEILCDD | 211 | Q12824 | |
| EEECMFPKATDMTFK | 536 | P13533 | |
| EMADPELMASTLETC | 2041 | O60287 | |
| ENLETFEEVVKPMME | 211 | Q92574 | |
| DPDMAMEICATDAVD | 321 | Q2NL82 | |
| DEMKVPDCAETFMTL | 471 | Q6NUQ1 | |
| EMEEMNTSEEEESPC | 416 | Q8WWL2 | |
| PEVVMCETMKDTPYD | 201 | O94804 | |
| PMDEDEDMTKTRTFF | 36 | Q8NFJ6 | |
| EMPKKECSEAMEVET | 706 | Q12888 | |
| MEEMEEELKCPVCGS | 1 | Q9C026 | |
| VIEMLEDEDMPCKDS | 126 | Q9UL58 | |
| NISKMAELFMECEEE | 11 | Q8ND82 | |
| MEAEETMECLQEFPE | 1 | P52739 | |
| MTFEEEKMQLACDDL | 76 | Q8N584 | |
| SSEKEEDVFMGMVCP | 1146 | O95071 | |
| MEPSTCRTMESEEDY | 1 | A6NNM8 | |
| FDESVVMPESQMCRK | 6 | Q96NK8 |